AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $137,190 | +8.9% | 10,923 | -3.9% | 0.06% | +10.3% |
| Q1 2023 | $126,027 | -16.7% | 11,364 | -8.3% | 0.06% | -1.7% |
| Q4 2022 | $151,246 | +17.2% | 12,387 | -0.3% | 0.06% | -20.3% |
| Q3 2022 | $129,000 | -27.1% | 12,427 | -25.0% | 0.07% | -24.5% |
| Q2 2022 | $177,000 | +7.3% | 16,565 | -5.5% | 0.10% | +100.0% |
| Q1 2022 | $165,000 | -22.2% | 17,520 | +90.9% | 0.05% | +28.9% |
| Q4 2020 | $212,000 | +31.7% | 9,178 | -19.7% | 0.04% | +15.2% |
| Q3 2020 | $161,000 | -15.3% | 11,430 | -9.5% | 0.03% | -19.5% |
| Q2 2020 | $190,000 | +62.4% | 12,623 | -0.7% | 0.04% | +41.4% |
| Q1 2020 | $117,000 | +8.3% | 12,713 | +15.0% | 0.03% | +31.8% |
| Q4 2019 | $108,000 | +27.1% | 11,057 | +3.9% | 0.02% | +15.8% |
| Q3 2019 | $85,000 | – | 10,645 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |